Skip to content

Brain Oscillations and Neural States

Relationship Between Brain Oscillations and Neural States

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07635615
Acronym
PHAROS
Enrollment
30
Registered
2026-06-09
Start date
2025-10-01
Completion date
2026-02-26
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transcranial Magnetic Stimilation

Brief summary

The study aims to investigate, through the use of electroencephalography (EEG), instantaneous brain states, namely rapid oscillations of the brain's electrical activity, and their relationship with behavior and brain functions. The study will focus on three main objectives: (1) establishing a relationship between brain oscillations and behavior; (2) establishing a relationship between brain oscillations and brain functions, in terms of neural responsiveness; and (3) identifying the different phases of brain oscillations and investigating any related modulations of behavior and brain functions. PHAROS will combine EEG with transcranial magnetic stimulation (TMS) to investigate and modulate brain states non-invasively.

Interventions

OTHERBehavioral Treatment

Imagining an abduction movement of the right index finger

Sponsors

IRCCS San Camillo, Venezia, Italy
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults

Exclusion criteria

* Left-handedness (assessed through the Oldfield test) * Diagnosis of neurological or psychiatric disorders * Vision problems that prevent reading, not correctable with lenses * Diagnosis of substance dependence on drugs or alcohol * Presence of hearing aids/prostheses * Diagnosis of epilepsy or family history up to the second degree with it * Episodes of febrile convulsions or recurrent fainting * Head trauma * Presence of surgical clips or metal implants in the head * Diagnosis of heart disease * Presence of a cardiac pacemaker or artificial heart valve * Presence of hearing aids/prostheses * Hearing problems or tinnitus * Vision problems not corrected with lenses (such as color blindness) * Taking tricyclic antidepressant medications * Taking neuroleptic medications * Diagnosis of headache or migraine * Taking more than 3 alcoholic units in the last 24 hours * Taking 2 or more cups of coffee or caffeine from other sources in the last 2 hours

Design outcomes

Primary

MeasureTime frameDescription
Motor-evoked potentialBaselineMotor-evoked potentials (MEPs) will be recorded from the right index-finger abductor muscle following single-pulse TMS delivered over the primary motor cortex. MEPs will be used as an index of corticospinal excitability. The main outcome measure will be the peak-to-peak MEP amplitude, calculated as the difference between the maximum and minimum EMG signal within the post-stimulation time window.
TMS-evoked potentialBaselineTMS-evoked potentials (TEPs) will be recorded using EEG following single-pulse TMS. TEPs will be used as an index of cortical responsiveness to stimulation. The main outcome measures will be the amplitude and latency of the main TEP components within predefined post-stimulation time windows.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026